The FDA and European Medicines Agency both reviewed the data on suicidality concerns and concluded theres no causal link between GLP-1 receptor agonist use and suicidality
Peak does not take insurance, but HSA and FSA funds are eligible, and the flat price already includes provider review, supplies, and shipping
Leading digital weight management solution providers already started to offer companion solutions for GLP-1 patients
Boxed warning updates for benzodiazepines
Glucagon-like peptide-1 (GLP-1) receptor agonists are licensed for type 2 diabetes and weight management, not inflammatory conditions
Contraindications include a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), or a known allergic reaction to the medication